Rosenberg, Howard E.

Howard E. Rosenberg  Ph.D. is a scientific advisor in the London office of Frommer, Lawrence and Haug, LLP. Dr. Rosenberg has spent over 30 years in the pharmaceutical industry and for much of that time has been involved in IP matters.

He qualified as a medicinal chemist, having read Chemistry at The Queen’s College, Oxford, and then completed a Ph.D. in the Pharmacy Department of the University of Manchester. He then entered the pharmaceutical industry and spent several years in medicinal chemistry research, firstly synthesising radio-labelled compounds at May and Baker and then 9 years at Beecham Pharmaceuticals researching into several different disease areas before changing direction and moving to Generics [UK] Ltd. in 1986. The company then became Merck Generics where he was the Group IP and API Strategy Director and was responsible for the start up of several distinct and diverse teams covering areas ranging from IP to API synthesis. He then ensured that these different groups were combined into one team and under his leadership they afforded strong scientific input into supporting the company worldwide. He was involved not only with Intellectual Property matters on an international scale but in Regulatory Affairs including assisting/visiting API facilities and assessing the corresponding Drug Master Files. He helped to instigate and develop the lobby organisation, now known as the European Generic medicines Association, EGA, for the European generics industry

He has given numerous presentations at various symposia both in UK and abroad covering IP issues, aspects of Active Pharmaceutical Ingredients (API’s) and other matters of concern to the generic industry.

Dr. Rosenberg has worked with law firms and attorneys on many pharmaceutical patent cases throughout the world.  Examples of the more significant cases are as follows:

Australia:
Omeprazole, ranitidine, escitalopram, paroxetine.
EU:
Omeprazole, ranitidine, paroxetine, alendronate, clarithromycin, seretide, citalopram, escitalopram, galantamine, levofloxacin
Canada:
Omeprazole, ranitidine, paroxetine, citalopram, escitalopram
USA:
Ranitidine, omeprazole, clarithromycin, paroxetine, galantamine, pioglitazone, escitalopram, levalbuterol

Dr. Rosenberg is a member of the Royal Society of Chemistry.